<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2022.867831</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Substance P Increases the Excitability of Dorsal Motor Nucleus of the Vagus Nerve <italic>via</italic> Inhibition of Potassium Channels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Eunhee</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1663113/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kim</surname> <given-names>Woojin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/711741/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname> <given-names>Yong Seek</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1671518/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jin</surname> <given-names>Young-Ho</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1601287/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiology, School of Medicine, Kyung Hee University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology, College of Korean Medicine, Kyung Hee University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Microbiology, School of Medicine, Kyung Hee University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Elena Lucarini, University of Florence, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Alessio Masi, University of Florence, Italy; Kenneth O&#x2019;Riordan, University College Cork, Ireland</p></fn>
<corresp id="c001">&#x002A;Correspondence: Young-Ho Jin, <email>jinyh@khu.ac.kr</email></corresp>
<corresp id="c002">Woojin Kim, <email>wjkim@khu.ac.kr</email></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>16</volume>
<elocation-id>867831</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Yang, Kim, Park and Jin.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Yang, Kim, Park and Jin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Increases in the substance P (SP) concentration in the medial portion of the dorsal motor nucleus of the vagus nerve (mDMV) in the brainstem are closely associated with chemotherapy induced nausea and vomiting (CINV). However, the underlying cellular and molecular mechanisms of action are not well understood. In this study, we investigated the effects of SP on mDMV neurons using whole-cell patch-clamp recordings from rat brainstem slices. Application of different concentrations of SP induced tonic and phasic responses. Submicromolar concentrations of induced an inward shift of the holding current by increasing membrane input resistance. The response was mimicked by acidification of the extracellular solution and inhibited by a neurokinin type 1 receptor antagonist. These responses have equilibrium potentials close to the K<sup>+</sup> equilibrium potential. In addition, a TWIK-related acid-sensitive K<sup>+</sup> channel 3 (TASK-3) inhibitor, PK-THPP, induced responses similar to those produced by submicromolar SP concentrations. Micromolar concentrations of SP facilitated &#x03B3;-aminobutyric acid (GABA) release but diminished glutamate release; these changes were blocked by a GABA<sub><italic>B</italic></sub> receptor antagonist and a neurokinin type 3 receptor antagonist, respectively. In current-clamp recordings, submicromolar SP concentrations increased neuronal excitability by depolarizing membrane potentials. However, neither the increase in SP concentration to the micromolar range nor the addition of GABA<sub><italic>A</italic></sub> and ionotropic glutamate receptor antagonists affected neuronal excitability. Thus, SP increases the excitability of mDMV neurons by inhibiting K<sup>+</sup> conductance.</p>
</abstract>
<kwd-group>
<kwd>chemotherapy</kwd>
<kwd>nausea and vomiting</kwd>
<kwd>neurokinin receptor</kwd>
<kwd>acid-sensitive potassium channel</kwd>
<kwd>leak potassium channel</kwd>
<kwd>substance P</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Research Foundation of Korea<named-content content-type="fundref-id">10.13039/501100003725</named-content></contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="30"/>
<page-count count="11"/>
<word-count count="6315"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Gastrointestinal toxicity is a common complication of cancer chemotherapy with cytotoxic agents. Nausea and vomiting (NV) are the most frequent and debilitating side effects and are closely related to substance P (SP)-mediated activation of neurokinin-1 receptor (NK1R) in the medulla oblongata (<xref ref-type="bibr" rid="B19">Mu&#x00F1;oz and Cove&#x00F1;as, 2014</xref>; <xref ref-type="bibr" rid="B29">Yamamoto et al., 2014</xref>; <xref ref-type="bibr" rid="B22">Okafor et al., 2017</xref>). In experiment with rats, intraperitoneal injection of a cytotoxic agent, cisplatin, elevated the levels of SP in the cerebrospinal fluid for 3 days and induced pica, an indicator of vomiting in rats (<xref ref-type="bibr" rid="B27">Tatsushima et al., 2011</xref>). Most neurons that innervate the upper gastrointestinal tract are found in the medial portion of the dorsal motor nuclei of the vagus nerve (mDMV) of the medulla and activate nicotinic acetylcholine receptors onto postganglionic neurons (<xref ref-type="bibr" rid="B2">Berthoud et al., 1991</xref>; <xref ref-type="bibr" rid="B7">Hornby, 2001</xref>; <xref ref-type="bibr" rid="B28">Travagli et al., 2006</xref>). Additionally, high levels of SP-containing axon terminals and NK receptors were identified in the mDMV (<xref ref-type="bibr" rid="B13">Ladic and Buchan, 1998</xref>; <xref ref-type="bibr" rid="B14">Le Brun et al., 2008</xref>). Therefore, elevated plasma SP levels during chemotherapy are expected to induce NV by activating NK1 receptors on mDMV neurons. However, the effect of SP on the excitability of mDMV neurons is not well understood. While the addition of the most recent NK1R antagonists to standard antiemetic regimen improved control of chemotherapy induced nausea and vomiting (CINV), numerous patients still experienced these effects (<xref ref-type="bibr" rid="B16">Lorusso et al., 2020</xref>; review). Further research is needed to understand the mechanisms underlying CINV to treat patients which are resistant to the current antiemetic regimens. Thus, we evaluated the effect of SP on mDMV neurons and investigated the cellular and molecular mechanisms underlying the responses in rat brainstem slices with electrophysiological methods.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Statement of Ethics Approval</title>
<p>All animal procedures were conducted with the approval of the institutional Animal Care and Use Committee. These procedures were in accordance with the National Veterinary Research and Quarantine Service guidelines of the Republic of Korea. Efforts were made to minimize the number of animals used and their suffering.</p>
</sec>
<sec id="S2.SS2">
<title>Dorsal Motor Nucleus of the Vagus Slice Preparation</title>
<p>Coronal brain stem slices were taken from 9- to 12-week-old male Sprague&#x2013;Dawley (SD) rats (KRIB&#x0026;B, Korea). The rats were deeply anesthetized with isoflurane (5%). The anesthesia level was confirmed by the absence of the flexor withdrawal reflex, after which the chest was compressed to stop the heart. The brainstem was removed and placed in 4&#x00B0;C artificial cerebrospinal fluid (ACSF) composed of (in mM) 125 NaCl, 3 KCl, 1.2 KH<sub>2</sub>PO<sub>4</sub>, 1.2 MgSO<sub>4</sub>, 25 NaHCO<sub>3</sub>, 10 dextrose, and 2 CaCl<sub>2</sub> and bubbled with 95% O<sub>2</sub>&#x2013;5% CO<sub>2</sub>. Acidic solutions (pH 6.8) were made by adding HCl. Coronal slices (300 &#x03BC;m thick) containing the DMV were cut using a microtome (VT-1200; Leica, Germany).</p>
</sec>
<sec id="S2.SS3">
<title>Experimental Design</title>
<p>Slices were secured with a polyethylene mesh in a perfusion chamber and perfused with ACSF at 34&#x2013;36&#x00B0;C and 307 mOsm. Recordings were then made from DMV neurons. Whole-cell recording pipettes were visually guided to mDMV neurons using infrared illumination and differential interference contrast optics (40X water immersion lens) on a BX51WI microscope (Olympus, Tokyo, Japan) coupled to an infrared-sensitive ZEISS Axiocam 503 mono camera (<xref ref-type="fig" rid="F1">Figure 1</xref>). Whole-cell patch-clamp recordings were carried out using a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA, United States). Voltage-clamp and current-clamp recordings were performed in the conventional whole-cell configuration. Recording electrodes (3&#x2013;3.5 M&#x03A9;) were filled with an intracellular solution containing the following (in mM): 10 NaCl, 40 KCl, 90 K gluconate, 11 EGTA, 1 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 10 HEPES, 2 Na<sub>2</sub>ATP, and 0.2 Na<sub>2</sub>GTP, pH 7.3 (295 mOsm). Under these ionic conditions, Cl<sup>&#x2013;</sup> selective currents at the holding potential (-50 mV) will be inward (E<sub><italic>Cl</italic></sub>- = -22.4 mV). All recordings were corrected for liquid junction potential. In voltage-clamp mode, 70&#x2013;75% series resistance compensation was achieved using the series resistance compensation feature of the amplifier. Input resistance measurements were performed by measuring the currents induced by hyperpolarizing steps to -60 and -100 mV. Whole-cell recordings were obtained from 87 visually identified mDMV neurons from different brain slices. Only one DMV slice was made from one animal.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Coronal slice of the brainstem. This 10&#x00D7; magnification micrograph of the rat brainstem slice was retained in a perfusion chamber with polyethylene strands. Pipette, recording electrode. AP, area postrema. CC, central canal. DMV, dorsal motor nucleus of the vagus. NTS, nucleus tractus solitarii.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g001.tif"/>
</fig>
</sec>
<sec id="S2.SS4">
<title>Materials</title>
<p>All drugs were administered via bath ACSF perfusate. A selective NK-1 receptor antagonist, sendide, was obtained from Enzo (Farmingdale, NY). A selective NK3 receptor antagonist SB223412 (SB); a selective TASK-1 channel blocker ML365, a selective TASK-3 channel blocker, PK-THPP, and 1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzoquinoxaline-7-sulfonamide (NBQX), 3-([(3,4-dichlorophenyl)methyl]amino]propyl)diethoxymethyl)phosphinic acid (CGP), D-2-amino-5-phosphonovalerate (AP5), SR95531 (gabazine), tetrodotoxin (TTX), and bicuculline were obtained from Tocris Bioscience (Ellisville, MO, United States). SP and picrotoxin were purchased from Sigma&#x2013;RBI (Natick, MA, United States). Different concentrations of SP were perfused for 6 to 20 min at a flow rate of 1.8&#x2013;2 ml/min. The synaptic responses over the final 5-min period of each concentration exposure were analyzed.</p>
</sec>
<sec id="S2.SS5">
<title>Data Analysis</title>
<p>All spontaneous inhibitory and excitatory postsynaptic currents (sIPSCs and sEPSCs) were detected and analyzed from digitized waveforms using MiniAnalysis (Synaptosoft, Decatur, GA), as described previously (<xref ref-type="bibr" rid="B9">Kim et al., 2018</xref>). Briefly, except for the determination of frequency rates, events &#x003C; 4 pA and those with multiple peaks were excluded from waveform analyses and rate calculations. Baseline currents were measured over a 2 ms section of the recorded traces prior to every detected event. For statistical comparisons of sEPSCs or sIPSCs, waveform amplitude, event frequency and baseline values across each group were averaged over the last 5 min of each cumulative concentration step. Cumulative distributions of spontaneous postsynaptic current response amplitudes, frequencies, and baseline currents were compared using Kolmogorov&#x2013;Smirnov (K&#x2013;S) non-parametric analysis. For comparing two groups, t test were used. Statistical comparisons of three or more groups were made with one-way ANOVA or repeated-measures ANOVAs (RM-ANOVA) followed by Bonferroni/Dunn <italic>post hoc</italic> testing, when appropriate (Statview 4.57; Abacus Concepts, SAS Campus Drive, Cary, NC). The chi-squared test was used to compare the effect of 0.1 and 1 &#x03BC;M SP on the proportion of firing neurons. All data presented are means &#x00B1; SDMs. Differences were considered statistically significant at P values of less than 0.05.</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<sec id="S3.SS1">
<title>Substance P Increases &#x03B3;-Aminobutyric Acid Release and Shifts Holding Current</title>
<p>All recorded neurons had sIPSCs and sEPSCs, as reported earlier (<xref ref-type="bibr" rid="B3">Browning and Travagli, 1999</xref>; <xref ref-type="bibr" rid="B15">Lewis and Travagli, 2001</xref>). We first examined the effect of SP on GABAergic sIPSCs in the presence of the glutamate receptor antagonist NBQX. Under these conditions, the mean frequency of the sIPSCs was 0.39 &#x00B1; 0.15 Hz. Application of submicromolar (0.1 and 0.3 &#x03BC;M) concentrations of SP had no effect on sIPSC frequency or amplitude but shifted the holding current more inward (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). Increasing the SP concentration to micromolar levels (1 and 3 &#x03BC;M) increased the inward level of the holding current and markedly increased the sIPSC frequency. These responses did not fully recover to control levels even after a 25 min washout with ACSF. As a result, brain slices treated with micromolar concentrations of SP were not used further. Even the lowest tested SP concentrations produced a significant inward shift in the holding current (<xref ref-type="fig" rid="F2">Figure 2C</xref>, control vs. 0.1 &#x03BC;M SP, <italic>p</italic> = 0.0001, K-S test). In addition, the sIPSC frequency increased when 1 and 3 &#x03BC;M SP were administrated (<xref ref-type="fig" rid="F2">Figure 2C</xref>, <italic>p</italic> = 0.0001, K-S test). In the 9 tested neurons, SP uniformly shifted the holding current inward, but the sIPSC frequency increased in only 8 of the 9 neurons. Across all neurons, 1 and 3 &#x03BC;M SP significantly increased the sIPSC frequency to 12.6 &#x00B1; 4.9 and 14.6 &#x00B1; 4.7 times the control frequency, respectively (<xref ref-type="fig" rid="F2">Figure 2D</xref>, <italic>p</italic> &#x003C; 0.016, vs. control, RM-ANOVA, <italic>n</italic> = 8). The SP concentrations had no effect on the amplitude of the sIPSC (<italic>P</italic> = 0.9, RM-ANOVA, <italic>n</italic> = 8). At all tested concentrations, the SP-induced holding current shifted inward (<italic>p</italic> &#x003C; 0.032, vs. control, RM-ANOVA, <italic>n</italic> = 9).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Concentration-dependent SP effect on sIPSCs and holding currents. sIPSCs were isolated by the continuous presence of NBQX (20 &#x03BC;M) at a holding potential of -50 mV. SP (0.1&#x2013;3 &#x03BC;M) was applied in a cumulating manner. The slices were washed with ACSF for 1 min before higher concentrations of SP ware applied. <bold>(A)</bold> The holding current increased proportionally with the SP concentration. Additionally, the frequency of sIPSCs increased at 1 &#x03BC;M SP. The dashed line indicates the mean holding current before SP treatment. <bold>(B)</bold> Diary plots display the event characteristics of the sIPSCs of representative neurons (upper traces) during the cumulative application of 0.1&#x2013;3 &#x03BC;M SP. The amplitude (top panel), frequency (middle panel), and holding current (bottom panel) for each detected sIPSC are displayed. <bold>(C)</bold> Corresponding cumulative fractions of event measurements shown for the individual sIPSCs in panel <bold>(B)</bold>. The subpanels show the effect of SP on sIPSC amplitude (top panel), interevent interval (middle panel) and holding current (bottom panel). The baseline holding currents were measured as the absolute current (pA) of the individual responses. <bold>(D)</bold> Summary aggregate data for sIPSC events and concurrent changes in the holding current recorded during application of NBQX (<italic>n</italic> = 9 to 8 neurons). Measurements were normalized by the control amplitude and frequency of the neurons before compiling the averages. Changes in the baseline holding currents were calculated as changes from the control condition in absolute pA.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>Substance P Reduces Synaptic Glutamate Release</title>
<p>The effect of SP on glutamatergic sEPSCs was recorded in the presence of the GABA<sub><italic>A</italic></sub> receptor antagonist gabazine. In the representative neuron shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, the cumulative application of 0.03 to 3 &#x03BC;M SP induced an inward shift in the holding current and reduced the sEPSC frequency (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). These responses did not fully recover to control levels even after a 20 min washout with ACSF. Statistical analysis revealed that all tested concentrations of SP reduced sEPSC frequency (<xref ref-type="fig" rid="F3">Figure 3C</xref>, <italic>p</italic> &#x003C; 0.03, K-S test) without affecting the amplitude (<italic>p</italic> &#x003E; 0.24, K-S test). At the same time, SP induced a significant shift in the holding current at all tested concentrations (<italic>p</italic> &#x003C; 0.0001, K-S test). Of the 7 tested neurons, SP induced an sEPSC frequency decrease in 6, but shifts in the holding current were observed in only 5 neurons. Summary aggregate data of the sEPSC events show that all tested concentrations of SP reduced the sEPSC frequency below control levels; however, a significant difference was observed only with the application of 1 and 3 &#x03BC;M SP (<italic>p</italic> &#x003C; 0.03, <italic>n</italic> = 6, RM-ANOVA). SP concentrations had no effect on the amplitude of the sEPSCs (<italic>p</italic> &#x003E; 0.1, RM-ANOVA, <italic>n</italic> = 7). At concentrations of 1 and 3 &#x03BC;M, SP treatment decreased the sEPSC frequency to 56.1 &#x00B1; 24.7% and 58.1 &#x00B1; 23.7% of the control frequency, respectively (<xref ref-type="fig" rid="F3">Figure 3D</xref>, <italic>p</italic> &#x003C; 0.001, RM-ANOVA, <italic>n</italic> = 6). In 5 of the SP-responsive neurons, all tested concentrations of SP induced an inward holding current (<italic>p</italic> &#x003C; 0.01, RM-ANOVA, <italic>n</italic> = 5). After 5 min of treatment with 0.03 to 3 &#x03BC;M SP, the baseline holding current shifted inward from the control level at all tested concentrations. In summary, SP suppressed synaptic glutamate release without affect holding current.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>SP effect on sEPSCs and holding currents. <bold>(A)</bold> Glutamatergic sEPSCs were isolated with gabazine (6 &#x03BC;M) and recorded at a holding potential of -50 mV. SP (0.03&#x2013;3 &#x03BC;M) was applied in a cumulative manner. The slices were washed with ACSF for 1 min before higher concentrations of SP were applied. The dashed line indicates the mean holding current before SP treatment. <bold>(B)</bold> Diary plots display the event characteristics of the sEPSCs of representative neurons (upper traces) during the cumulative application of 0.03&#x2013;3 &#x03BC;M SP. The amplitude (top panel), frequency value (second panel), and holding current (bottom panel) values for each detected sEPSC are displayed. <bold>(C)</bold> Corresponding cumulative fractions of event measurements shown for each of the individual sEPSCs shown in <bold>(B)</bold>. Each panel shows the effect of SP on the sEPSC amplitude (top panel), interevent interval (middle panel) and holding current (bottom panel). The baseline holding currents were measured as the absolute current (pA) of the individual responses. <bold>(D)</bold> Summary aggregate data for sEPSCs. Measurements were normalized by the control amplitude and frequency of the neurons before compiling the averages. Changes in the baseline holding currents were calculated as changes from the control condition in absolute pA.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Substance P Induces an Inward Shift of the Holding Current</title>
<p>In this experiment, SP induced an inward shift in the holding current at a resting potential of -50 mV. To examine this more closely, we measured the holding current with increasingly hyperpolarized steps up to -120 mV in the presence of tetrodotoxin (TTX), NBQX and picrotoxin. In all tested neurons (<italic>n</italic> = 5), 0.01 to 1 &#x03BC;M SP reduced the membrane current at all tested holding potentials (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The steady-state current-voltage (I-V) relationships for the control condition and 0.1 &#x03BC;M SP application cross were &#x2013;89 mV (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The average value of -87.6 &#x00B1; 0.8 mV (<italic>n</italic> = 5) was close to the potassium equilibrium potential (E<sub><italic>k</italic></sub>) -86 mV. <xref ref-type="fig" rid="F4">Figure 4C</xref> summarizes the baseline holding currents for the control conditions and during SP application. SP also increased membrane input resistance in a concentration-dependent manner (<xref ref-type="fig" rid="F4">Figure 4D</xref>). Taken together, the results suggest that the inward shift in the holding current and the increase in input resistance were both driven by the inhibition of K<sup>+</sup> conductance.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>SP inhibits background conductance. <bold>(A)</bold> Current traces from hyperpolarizing voltage steps applied in control conditions and during application of 0.1 to 1 &#x03BC;M SP. Dashed lines indicate control potential. <bold>(B)</bold> The current-voltage (I-V) relation measured from the same cell in <bold>(A)</bold>. <bold>(C)</bold> Average baseline holding current recorded from cells in the control condition and during application of 0.01 to 1 &#x03BC;M SP. &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01. <bold>(D)</bold> Input resistance in the control and during application of 0.01, 0.1, and 1 &#x03BC;M SP were 231.8 &#x00B1; 74.9, 275.4 &#x00B1; 93.1, 313.1 &#x00B1; 109.9, and 337.2 &#x00B1; 122.8 M&#x03A9;, respectively (<italic>n</italic> = 5).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g004.tif"/>
</fig>
</sec>
<sec id="S3.SS4">
<title>Acidification Reduces Background Channel Conductance</title>
<p>Substance P (SP) reduces the membrane current, but this finding raises the question of the current identity. The tandem pore domain K<sup>+</sup> channel provides a prominent leak current in many central neurons, and its mRNA is present at high levels in the DMV (<xref ref-type="bibr" rid="B5">Duprat et al., 1997</xref>; <xref ref-type="bibr" rid="B25">Talley et al., 2000</xref>). Neurotransmitters, including SP, inhibit the tandem pore domain in a weak inwardly rectifying (TWIK)-related acid-sensitive potassium (TASK) channel, similar to the effect of acidification (<xref ref-type="bibr" rid="B25">Talley et al., 2000</xref>). Thus, we tested the pH sensitivity of the background-leak current in our mDMV neurons by measuring the steady state I-V relationships in the continuous presence of TTX, gabazine (GZ), and NBQX. Acidification of the extracellular solution (pH 6.8) from the control condition (pH 7.4) reduced the current responses at all voltage steps, in 78% of the tested neurons (<italic>n</italic> = 14/18, respectively; <xref ref-type="fig" rid="F5">Figure 5A</xref>). The mean holding current at pH 6.8 was significantly less than that of the control condition at pH 7.4 (<xref ref-type="fig" rid="F5">Figure 5C</xref>). The mean holding currents at pH 7.4 and 6.8 were 43.5 &#x00B1; 67.3 and 1.1 &#x00B1; 61.6 pA, respectively. The I-V relationship had a reversal potential of -86 &#x00B1; 0.5 mV (<xref ref-type="fig" rid="F5">Figure 5B</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Background K<sup>+</sup> conductance was reduced by acidification. <bold>(A)</bold> Current traces in response to polarizing voltage steps between -50 and -120 mV from the holding potential of (-50 mV) applied to the same cell during application of pH 7.4 and pH 6.8 ACSF. All traces were recorded during the application of TTX (1 &#x03BC;M). The current response was measured 10 ms after the onset of the voltage step to avoid inclusion of the transient capacitance. <bold>(B)</bold> The I-V relationship measured from the same cell in <bold>(A)</bold>. <bold>(C)</bold> Mean baseline holding current at normal ACSF (pH 7.4) and during acidification (pH 6.8). Each bar and whisker represent the mean &#x00B1; SDM from 5 different cells. &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS5">
<title>The TWIK-Related Acid-Sensitive K<sup>+</sup> Channel Affects Holding Current</title>
<p>The above results suggest that TASK channels participate in the SP-induced inward shift in the holding current and reduced input resistance. Indeed, high mRNA levels of TASK-1 and TASK-3 are found in the rodent DMV, while other two-pore domain K<sup>+</sup> channel transcripts are expressed at lower levels (<xref ref-type="bibr" rid="B26">Talley et al., 2001</xref>). Hence, we characterized the background K<italic><sup>+</sup></italic> current using selective inhibitors of TASK-1 and TASK-3. Application of a selective TASK-3 blocker, PK-THPP, induced similar responses as acidification (<xref ref-type="fig" rid="F6">Figure 6</xref>). In all tested neurons (<italic>n</italic> = 5), the application of PK-THPP shifted the baseline holding current inward by approximately 9.6 &#x00B1; 2.9 pA and reduced the membrane current. Meanwhile, application of a TASK-1 inhibitor, ML365, did not significantly affect the baseline holding current or membrane resistance (<italic>n</italic> = 5). Taken together, the results show that TASK-3 channels are likely involved in the regulation of excitability of mDMV neurons.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>DMV neurons express a leak K<sup>+</sup> conductance similar to TASK-3 neurons. <bold>(A)</bold> Current traces from hyperpolarizing voltage steps (increment: -10 mV, range: from -50 to -120 mV) applied in control conditions and during application of PK-THPP (0.1 &#x03BC;M). Average baseline holding current recorded from cells in the control condition and during application of PK-THPP &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01 (<italic>n</italic> = 5). <bold>(B)</bold> Current traces from hyperpolarizing voltage steps applied in control conditions and during application of ML365 (10 nM). Dashed lines indicate current level at -50 mV.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g006.tif"/>
</fig>
</sec>
<sec id="S3.SS6">
<title>Substance P Acts on Different NK Receptors</title>
<p>Substance P (SP) binds to all three NK receptor subtypes (NK1, NK2 and NK3), but NK1 has the highest affinity for SP. The expression of NK1 and NK3 receptors has been reported in rat DMV but not that of NK2 (<xref ref-type="bibr" rid="B24">Saffroy et al., 2003</xref>). Our lowest SP concentration (0.03 &#x03BC;M) preferentially induced a holding current shift without altering the sIPSC frequency. To isolate SP action, we tested the NK1 selective antagonist sendide, which affects SP-mediated responses (<xref ref-type="bibr" rid="B15">Lewis and Travagli, 2001</xref>). Sendide (1 &#x03BC;M) alone did not affect the holding current or frequency of the sIPSCs (<xref ref-type="fig" rid="F7">Figure 7A</xref>). In the continuous presence of sendide, neither 0.1 nor 1 &#x03BC;M SP affected the holding current (RM-ANOVA, <italic>p</italic> &#x003E; 0.45, <italic>n</italic> = 8). In contrast, 1 &#x03BC;M SP significantly increased the sIPSC frequency despite the presence of the NK1 antagonist in 6 of 8 tested neurons (RM-ANOVA, <italic>p</italic> = 0.03). The mean frequency of the sIPSCs measured before and after application of 1 &#x03BC;M SP was 2.9 &#x00B1; 0.8 Hz and 8.9 &#x00B1; 3.86 Hz, respectively (<italic>n</italic> = 6). In separate experiments, the effect of NK3R on the SP-mediated holding current and sIPSC frequency was tested in 6 different neurons. The NK3R antagonist, SB223412 (1 &#x03BC;M, SB), alone did not affect the holding current or frequency of the sIPSCs (<xref ref-type="fig" rid="F7">Figure 7B</xref>). In the presence of SB (1 &#x03BC;M), perfusion with 0.1 and 1 &#x03BC;M SP shifted the holding current inward (RM-ANOVA, &#x002A;&#x002A; <italic>p</italic> &#x003C; 0.003, &#x002A; <italic>p</italic> &#x003C; 0.012, <italic>n</italic> = 6). Neither 0.1 nor 1 &#x03BC;M SP induced any significant changes in sIPSC frequency (<italic>p</italic> &#x003E; 0.4, <italic>n</italic> = 6).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>NK receptors affect SP-mediated presynaptic GABA release and postsynaptic holding current. sIPSCs were isolated by recording in the continuous presence of NBQX (20 &#x03BC;M). <bold>(A)</bold> Original traces show the effect of sendide alone, sendide + 0.1 &#x03BC;M SP, and sendide + 1 &#x03BC;M SP. All traces were obtained from a single neuron. The histograms summarize the holding currents and mean frequencies of the sIPSCs from 6 different neurons. <bold>(B)</bold> Original traces show the effects of 1 &#x03BC;M SB223412 (SB), SB + 0.1 &#x03BC;M SP, and SB + 1 &#x03BC;M SP. All traces were obtained from a single neuron. The histograms summarize the holding currents and mean frequencies of the sIPSCs from 6 different neurons. Each point and error bar represent the mean &#x00B1; SDM from 9 different cells. &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, &#x002A; <italic>p</italic> &#x003C; 0.05.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g007.tif"/>
</fig>
</sec>
<sec id="S3.SS7">
<title>Heterosynaptic Regulation of Glutamate Release</title>
<p>In this study, micromolar concentrations of SP facilitated synaptic GABA release by activating NK3R and suppressed synaptic glutamate release via an unknown mechanism. In the neuronal circuitry of the brain stem, glutamatergic and GABAergic synaptic responses are often influenced by metabotropic receptor-mediated heterosynaptic modulation (<xref ref-type="bibr" rid="B8">Jin et al., 2004</xref>; <xref ref-type="bibr" rid="B6">Fernandes et al., 2011</xref>). To test whether a GABA<sub><italic>B</italic></sub> receptor antagonist altered glutamate release, we tested the effect of SP in the presence of the selective GABA<sub><italic>B</italic></sub> receptor antagonist CGP. The application of SP under control conditions decreased sEPSC rates, and the addition of the CGP blocked the SP-induced reduction in sEPSCs (<xref ref-type="fig" rid="F8">Figure 8</xref>). The mean frequency of the sIPSC at control, SP, and SP + CGP was 2.1 &#x00B1; 0.45, 1.14 &#x00B1; 0.47 and 2.2 &#x00B1; 0.47, respectively. Thus, our results imply that the SP-mediated increase in the release of GABA reduced synaptic glutamate release from glutamatergic neurons via GABA<sub><italic>B</italic></sub> receptor activation. Perfusion of 1 &#x03BC;M SP reduced the sEPSC frequency to 60% of the control frequency (<xref ref-type="fig" rid="F8">Figure 8</xref>, <italic>p</italic> = 0.045, RM -ANOVA, <italic>n</italic> = 5). In the same set of neurons, however, SP failed to reduce the sEPSC frequency in the presence of 5 &#x03BC;M CGP (<italic>p</italic> = 0.78, RM -ANOVA, <italic>n</italic> = 5). However, in the same experiments SP application shifted the holding current inward. The mean holding current at control, SP, and SP + CGP was 10.4 &#x00B1; 15.8 pA, 31.6 &#x00B1; 23.8 pA and 30.8 &#x00B1; 21.3 pA, respectively.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption><p>The effect of a GABA<sub><italic>B</italic></sub> receptor antagonist on sEPSC frequency. Representative current traces from a single neuron show the effect of SP (1 &#x03BC;M) and CGP (5 &#x03BC;M) on sEPSCs. The sEPSC frequency data were obtained from 5 different neurons. All columns and error bars indicate the mean &#x00B1; SDM, &#x002A; <italic>P</italic> &#x003C; 0.05.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g008.tif"/>
</fig>
</sec>
<sec id="S3.SS8">
<title>Substance P Increases Neuronal Excitability</title>
<p>These multiple effects on synaptic transmission as well as membrane conductance indicate that SP may alter neuronal excitability. To assess this in single neurons, we exposed neurons first to 0.1 &#x03BC;M SP under voltage-clamp and then followed that with current-clamp recordings of the responses. Application of 0.1 &#x03BC;M SP induced an inward current under voltage-clamp conditions (<xref ref-type="fig" rid="F9">Figure 9A</xref>). During the current-clamp, 0.1&#x03BC;M SP both depolarized and elicited action potentials, as shown in the representative neuronal tracings in <xref ref-type="fig" rid="F9">Figure 9</xref>. A high concentration of SP (1 &#x03BC;M) failed to increase the firing rate (<xref ref-type="fig" rid="F9">Figure 9B</xref>). In twelve tested neurons, application of 0.1 &#x03BC;M SP shifted the holding current inward (<xref ref-type="fig" rid="F10">Figure 10A</xref>). The mean holding current before and during 0.1 &#x03BC;M SP application was 32.3 &#x00B1; 11.5 pA and -47.9 &#x00B1; 21.3 pA, respectively. During the current-clamp, the neurons averaged a resting potential of -59.7 &#x00B1; 2.6 mV in the control condition and 25% (<italic>n</italic> = 3/12) spontaneously fired action potentials. Application of 0.1 &#x03BC;M SP depolarized the mean resting membrane potential to -50.3 &#x00B1; 2.6 mV; 75% of neurons fired action potentials in this condition (<xref ref-type="fig" rid="F10">Figure 10B</xref>, <italic>n</italic> = 9/12). The application of 1 &#x03BC;M SP did not further affect the firing rate (<italic>p</italic> &#x003E; 0.6, n = 12, RM ANOVA) or the percentage of firing neurons (<italic>p</italic> = 0.4, chi-square test). In the presence of 1 &#x03BC;M SP, the addition of GZ (<italic>p</italic> = 0.38, <italic>n</italic> = 11, paired <italic>t</italic> test) or the coapplication of GZ and NBQX (<italic>p</italic> = 0.65, <italic>n</italic> = 10, paired <italic>t</italic> test) failed to induce significant changes in action potential frequency (<xref ref-type="fig" rid="F10">Figure 10C</xref>).</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption><p>The effect of SP on holding current and membrane potential. <bold>(A)</bold> Current traces were recorded in voltage-clamp mode before and during application of 0.1 &#x03BC;M SP at a holding potential of -50 mV. The dotted line represents 0 pA. <bold>(B)</bold>. Membrane potential traces were recorded before and during a 5 min application of SP at 0.1, 1 &#x03BC;M and 1 &#x03BC;M + gabazine (GZ) 6 &#x03BC;M. All traces were obtained from the same neuron. The dotted line represents -50 mV.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g009.tif"/>
</fig>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption><p>SP-induced depolarization is a major contributor to action potential firing. <bold>(A)</bold> The holding current was recorded before and during a 5 min application of 0.1 &#x03BC;M SP at a holding potential of -50 mV (<italic>n</italic> = 12). <bold>(B)</bold> The resting membrane potential was recorded from the same set of neurons as in <bold>(A)</bold> in current clamp mode without current injection. Connected points represent measurements from individual cells before and after application of 0.1 &#x03BC;M SP. <bold>(C)</bold> The action potential frequency was calculated under the control conditions and after application of 0.1 and 1 &#x03BC;M SP, 1 &#x03BC;M SP + gabazine, and 1 &#x03BC;M SP + gabazine + NBQX (20 &#x03BC;M) (<italic>n</italic> = 12). All columns and error bars indicate the mean &#x00B1; SDM, &#x002A; <italic>P</italic> &#x003C; 0.05 vs. control.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-867831-g010.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we tested the response of mDMV neurons to SP to elucidate the mechanism of action underlying CINV at the molecular and cellular levels. Submicromolar concentrations of SP induced an inward shift in the baseline current by decreasing membrane K<sup>+</sup> conductance. SP-induced responses were mimicked by acidification of the extracellular solution and application of TASK-3 blockers but were blocked by application of NK1R antagonists. Micromolar concentrations of SP increased synaptic GABA release in an NK-3R activity-dependent manner but reduced the frequency of spontaneous EPSCs in a GABA<sub><italic>B</italic></sub> receptor activity dependent manner. In a current-clamp experiment, application of submicromolar SP caused membrane depolarization and firing activity in mDMV neurons. However, no significant changes were observed upon further elevation of the SP concentrations to micromolar ranges.</p>
<p>NK1 receptor antagonists have been used in combination with corticosteroids and 5-HT3 receptor antagonists to prevent CINV associated with highly emetogenic agents. However, a significant number of cancer patients still suffer from CINV (<xref ref-type="bibr" rid="B4">Dranitsaris et al., 2017</xref>; <xref ref-type="bibr" rid="B20">Nurgali et al., 2018</xref>). Hence, the development of new classes of antiemetic drugs is needed. In our experiment, SP action on NK1R receptor increased the excitability of mDMV neurons by reducing K<sup>+</sup> efflux through TASK-3 channels. Therefore, the activity of TASK-3 plays a decisive role in the regulation of the excitability of mDMV neurons; a substance that activates TASK-3 is expected to suppress CINV by hyperpolarizing mDMV neurons. Interestingly, TASK-3 channel activators are already in clinical use for general anesthesia, rather than antiemetic purposes. For example, some halogenated volatile anesthetics (e.g., halothane and isoflurane) are known to induce anesthesia by hyperpolarizing membrane potential via activation of TASK channels (<xref ref-type="bibr" rid="B17">Meuth et al., 2009</xref>; <xref ref-type="bibr" rid="B18">Muhammad et al., 2010</xref>; <xref ref-type="bibr" rid="B30">Yao et al., 2017</xref>). However, systemic use of these anesthetics is known to cause NV rather than inhibit it. Therefore, it appears that targeted delivery of TASK-3 activators to mDMV is required to inhibit CINV. However, this is currently impossible.</p>
<p>A more feasible way to inhibit CINV is to increase the K<sup>+</sup> conductance of TASK-3 channels by alkalizing the blood. The open probability of the TASK-3 channel increases with alkalization (<xref ref-type="bibr" rid="B23">Rajan et al., 2000</xref>). Thus, elevation of the blood plasma pH is expected to interrupt SP-induced activation of mDMV neurons. Typically, pH levels in the blood are determined by the partial pressure of oxygen (PO<sub>2</sub>) and carbon dioxide (PCO<sub>2</sub>). A Japanese research group showed that mild hyperthermia induced alkalization of blood pH in advanced cancer patients by increased PO<sub>2</sub> and decreased PCO<sub>2</sub> in the blood (<xref ref-type="bibr" rid="B21">Ohishi et al., 2009</xref>). Their findings showed that 30 min of hyperthermia (39.5&#x00B0;C) increased blood pH from less than 7.4 to pH 7.7; this improved clinical responses but effects on gastrointestinal function were not evaluated. In addition, electrophysiological recording of the TASK-3 channel showed that the open probability of the K<sup>+</sup> channel continuously increases during elevation of the pH of from 6 to 8 (<xref ref-type="bibr" rid="B10">Kim et al., 2000</xref>). Taken together, our findings suggest the possibility of inhibiting CINV resistance to antiemetic regimens by increasing body temperature. However, further clinical studies are needed to elucidate the potential of thermotherapy-induced antiemetic action.</p>
<p>In this experiment, SP-mediated tonic current shifts and spontaneous increases in GABA release were inhibited by NK1 and NK3 receptor antagonists, respectively. These results imply segregated expression of NK receptors on different neurons. An immunohistochemistry study of DMV neurons showed that most NK1-positive neurons were cholinergic, whereas NK3-positive neurons were non-cholinergic (<xref ref-type="bibr" rid="B14">Le Brun et al., 2008</xref>). In addition, NK1R expression was identified in retrogradely labeled vagal efferent DMV neurons that innervate the stomach or duodenum (<xref ref-type="bibr" rid="B12">Ladic and Buchan, 1996</xref>; <xref ref-type="bibr" rid="B11">Krowicki and Hornby, 2000</xref>; <xref ref-type="bibr" rid="B15">Lewis and Travagli, 2001</xref>). Furthermore most efferent cholinergic DMV neurons exclusively innervate the stomach (<xref ref-type="bibr" rid="B1">Altschuler et al., 1991</xref>; <xref ref-type="bibr" rid="B2">Berthoud et al., 1991</xref>; <xref ref-type="bibr" rid="B12">Ladic and Buchan, 1996</xref>). In contrast, the NK3 receptor is predominantly expressed in GABAergic inhibitory interneurons (<xref ref-type="bibr" rid="B14">Le Brun et al., 2008</xref>).</p>
</sec>
<sec id="S5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="S6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Institutional Animal Care and Use Committee of the Kyung Hee university.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>EY and WK performed the experiments and drafted the manuscript. YP and Y-HJ generated the concept of the study and supervised the work. Y-HJ contributed to drafting and revising the manuscript. All authors of this manuscript have read and approved the manuscript for submission.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="pudiscl1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="S8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by a grant from the National Research Foundation of Korea (NRF-2017R1D1A1B03033436).</p>
</sec>
<ack><p>We thank M.C. Andresen for the critical reading of this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschuler</surname> <given-names>S. M.</given-names></name> <name><surname>Ferenci</surname> <given-names>D. A.</given-names></name> <name><surname>Lynn</surname> <given-names>R. B.</given-names></name> <name><surname>Miselis</surname> <given-names>R. R.</given-names></name></person-group> (<year>1991</year>). <article-title>Representation of the cecum in the lateral dorsal motor nucleus of the vagus nerve and commissural subnucleus of the nucleus Tractus solitarii in rat.</article-title> <source><italic>J. Comp. Neurol.</italic></source> <volume>304</volume> <fpage>261</fpage>&#x2013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903040209</pub-id> <pub-id pub-id-type="pmid">1707898</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berthoud</surname> <given-names>H. R.</given-names></name> <name><surname>Carlson</surname> <given-names>N. R.</given-names></name> <name><surname>Powley</surname> <given-names>T. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Topography of efferent vagal innervation of the rat gastrointestinal tract.</article-title> <source><italic>Am. J. Physiol.</italic></source> <volume>260</volume>(<issue>1 Pt 2</issue>), <fpage>R200</fpage>&#x2013;<lpage>R207</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.1991.260.1.R200</pub-id> <pub-id pub-id-type="pmid">1992820</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname> <given-names>K. N.</given-names></name> <name><surname>Travagli</surname> <given-names>R. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV).</article-title> <source><italic>Br. J. Pharmacol</italic>.</source> <volume>128</volume> <fpage>1307</fpage>&#x2013;<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0702908</pub-id> <pub-id pub-id-type="pmid">10578146</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dranitsaris</surname> <given-names>G.</given-names></name> <name><surname>Molassiotis</surname> <given-names>A.</given-names></name> <name><surname>Clemons</surname> <given-names>M.</given-names></name> <name><surname>Roeland</surname> <given-names>E.</given-names></name> <name><surname>Schwartzberg</surname> <given-names>L.</given-names></name> <name><surname>Dielenseger</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting.</article-title> <source><italic>Ann. Oncol.</italic></source> <volume>28</volume> <fpage>1260</fpage>&#x2013;<lpage>1267</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdx100</pub-id> <pub-id pub-id-type="pmid">28398530</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duprat</surname> <given-names>F.</given-names></name> <name><surname>Lesage</surname> <given-names>F.</given-names></name> <name><surname>Fink</surname> <given-names>M.</given-names></name> <name><surname>Reyes</surname> <given-names>R.</given-names></name> <name><surname>Heurteaux</surname> <given-names>C.</given-names></name> <name><surname>Lazdunski</surname> <given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>TASK, a human background K+ channel to sense external pH variations near physiological pH.</article-title> <source><italic>EMBO J.</italic></source> <volume>16</volume> <fpage>5464</fpage>&#x2013;<lpage>5471</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.17.5464</pub-id> <pub-id pub-id-type="pmid">9312005</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>L. G.</given-names></name> <name><surname>Jin</surname> <given-names>Y. H.</given-names></name> <name><surname>Andresen</surname> <given-names>M. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Heterosynaptic crosstalk: GABA-glutamate metabotropic receptors interactively control glutamate release in solitary tract nucleus.</article-title> <source><italic>Neuroscience</italic></source> <volume>174</volume> <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.11.053</pub-id> <pub-id pub-id-type="pmid">21129447</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hornby</surname> <given-names>P. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Central neurocircuitry associated with emesis.</article-title> <source><italic>Am. J. Med.</italic></source> <volume>111</volume>(<issue>Suppl. 8A</issue>), <fpage>106S</fpage>&#x2013;<lpage>112S</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9343(01)00849-x</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>Y. H.</given-names></name> <name><surname>Bailey</surname> <given-names>T. W.</given-names></name> <name><surname>Andresen</surname> <given-names>M. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Cranial afferent glutamate heterosynaptically modulates GABA release onto second-order neurons via distinctly segregated metabotropic glutamate receptors.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>24</volume> <fpage>9332</fpage>&#x2013;<lpage>9340</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1991-04.2004</pub-id> <pub-id pub-id-type="pmid">15496669</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>S. M.</given-names></name> <name><surname>Oh</surname> <given-names>B.</given-names></name> <name><surname>Tak</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>E.</given-names></name> <name><surname>Jin</surname> <given-names>Y. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Allopregnanolone Effects on Transmission in the Brain Stem Solitary Tract Nucleus (NTS).</article-title> <source><italic>Neuroscience</italic></source> <volume>379</volume> <fpage>219</fpage>&#x2013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>Y.</given-names></name> <name><surname>Bang</surname> <given-names>H.</given-names></name> <name><surname>Kim</surname> <given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>TASK-3, a new member of the tandem pore K(+) channel family.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>275</volume> <fpage>9340</fpage>&#x2013;<lpage>9347</lpage>.</citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krowicki</surname> <given-names>Z. K.</given-names></name> <name><surname>Hornby</surname> <given-names>P. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat.</article-title> <source><italic>J. Pharmacol. Exp. Ther.</italic></source> <volume>293</volume> <fpage>214</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="pmid">10734172</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ladic</surname> <given-names>L. A.</given-names></name> <name><surname>Buchan</surname> <given-names>A. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Association of substance P and its receptor with efferent neurons projecting to the greater curvature of the rat stomach.</article-title> <source><italic>J. Auton. Nerv. Syst.</italic></source> <volume>58</volume> <fpage>25</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1838(96)00114-2</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ladic</surname> <given-names>L. A.</given-names></name> <name><surname>Buchan</surname> <given-names>A. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Three-dimensional spatial relationship of neuropeptides and receptors in the rat dorsal vagal complex.</article-title> <source><italic>Brain Res.</italic></source> <volume>795</volume> <fpage>312</fpage>&#x2013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(98)00299-6</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Brun</surname> <given-names>I.</given-names></name> <name><surname>Dufour</surname> <given-names>A.</given-names></name> <name><surname>Crest</surname> <given-names>M.</given-names></name> <name><surname>Szab&#x00F3;</surname> <given-names>G.</given-names></name> <name><surname>Erdelyi</surname> <given-names>F.</given-names></name> <name><surname>Baude</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Differential expression of Nk1 and NK3 neurokinin receptors in neurons of the nucleus tractus solitarius and the dorsal vagal motor nucleus of the rat and mouse.</article-title> <source><italic>Neuroscience</italic></source> <volume>152</volume> <fpage>56</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.12.024</pub-id> <pub-id pub-id-type="pmid">18222044</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>M. W.</given-names></name> <name><surname>Travagli</surname> <given-names>R. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Effects of substance P on identified neurons of the rat dorsal motor nucleus of the vagus.</article-title> <source><italic>Am. J. Physiol. Gastrointest. Liver Physiol.</italic></source> <volume>281</volume> <fpage>G164</fpage>&#x2013;<lpage>G172</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.2001.281.1.G164</pub-id> <pub-id pub-id-type="pmid">11408269</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorusso</surname> <given-names>V.</given-names></name> <name><surname>Russo</surname> <given-names>A.</given-names></name> <name><surname>Giotta</surname> <given-names>F.</given-names></name> <name><surname>Codega</surname> <given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Management of Chemotherapy-Induced Nausea and Vomiting (CINV): a short review on the role of Netupitant-Palonosetron (NEPA).</article-title> <source><italic>Core Evid.</italic></source> <volume>15</volume> <fpage>21</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.2147/CE.S203634</pub-id> <pub-id pub-id-type="pmid">32802009</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meuth</surname> <given-names>S. G.</given-names></name> <name><surname>Kleinschnitz</surname> <given-names>C.</given-names></name> <name><surname>Broicher</surname> <given-names>T.</given-names></name> <name><surname>Austinat</surname> <given-names>M.</given-names></name> <name><surname>Braeuninger</surname> <given-names>S.</given-names></name> <name><surname>Bittner</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The neuroprotective impact of the leak potassium channel TASK1 on stroke development in mice.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>33</volume> <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.09.006</pub-id> <pub-id pub-id-type="pmid">18930826</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muhammad</surname> <given-names>S.</given-names></name> <name><surname>Aller</surname> <given-names>M. I.</given-names></name> <name><surname>Maser-Gluth</surname> <given-names>C.</given-names></name> <name><surname>Schwaninger</surname> <given-names>M.</given-names></name> <name><surname>Wisden</surname> <given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure.</article-title> <source><italic>Neuroscience</italic></source> <volume>167</volume> <fpage>758</fpage>&#x2013;<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.02.024</pub-id> <pub-id pub-id-type="pmid">20167264</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x00F1;oz</surname> <given-names>M.</given-names></name> <name><surname>Cove&#x00F1;as</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Involvement of substance P and the NK-1 receptor in human pathology.</article-title> <source><italic>Amino Acids</italic></source> <volume>46</volume> <fpage>1727</fpage>&#x2013;<lpage>1750</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-014-1736-9</pub-id> <pub-id pub-id-type="pmid">24705689</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nurgali</surname> <given-names>K.</given-names></name> <name><surname>Jagoe</surname> <given-names>R. T.</given-names></name> <name><surname>Abalo</surname> <given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Editorial: adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?</article-title> <source><italic>Front. Pharmacol.</italic></source> <volume>9</volume>:<issue>245</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00245</pub-id> <pub-id pub-id-type="pmid">29623040</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohishi</surname> <given-names>T.</given-names></name> <name><surname>Nukuzuma</surname> <given-names>C.</given-names></name> <name><surname>Seki</surname> <given-names>A.</given-names></name> <name><surname>Watanabe</surname> <given-names>M.</given-names></name> <name><surname>Tomiyama-Miyaji</surname> <given-names>C.</given-names></name> <name><surname>Kainuma</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Alkalization of blood pH is responsible for survival of cancer patients by mild hyperthermia.</article-title> <source><italic>Biomed. Res.</italic></source> <volume>30</volume> <fpage>95</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.2220/biomedres.30.95</pub-id> <pub-id pub-id-type="pmid">19420732</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okafor</surname> <given-names>D.</given-names></name> <name><surname>Kaye</surname> <given-names>A. D.</given-names></name> <name><surname>Kaye</surname> <given-names>R. J.</given-names></name> <name><surname>Urman</surname> <given-names>R. D.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of neurokinin-1 (substance P) antagonists in the prevention of postoperative nausea and vomiting.</article-title> <source><italic>J. Anaesthesiol. Clin. Pharmacol.</italic></source> <volume>33</volume> <fpage>441</fpage>&#x2013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.4103/0970-9185.222511</pub-id> <pub-id pub-id-type="pmid">29416232</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname> <given-names>S.</given-names></name> <name><surname>Wischmeyer</surname> <given-names>E.</given-names></name> <name><surname>Xin Liu</surname> <given-names>G.</given-names></name> <name><surname>Preisig-M&#x00FC;ller</surname> <given-names>R.</given-names></name> <name><surname>Daut</surname> <given-names>J.</given-names></name> <name><surname>Karschin</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An extracellular histiding as pH sensor.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>275</volume> <fpage>16650</fpage>&#x2013;<lpage>16657</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M000030200</pub-id> <pub-id pub-id-type="pmid">10747866</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saffroy</surname> <given-names>M.</given-names></name> <name><surname>Torrens</surname> <given-names>Y.</given-names></name> <name><surname>Glowinski</surname> <given-names>J.</given-names></name> <name><surname>Beaujouan</surname> <given-names>J. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites.</article-title> <source><italic>Neuroscience</italic></source> <volume>116</volume> <fpage>761</fpage>&#x2013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(02)00748-0</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talley</surname> <given-names>E. M.</given-names></name> <name><surname>Lei</surname> <given-names>Q.</given-names></name> <name><surname>Sirois</surname> <given-names>J. E.</given-names></name> <name><surname>Bayliss</surname> <given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons.</article-title> <source><italic>Neuron</italic></source> <volume>25</volume> <fpage>399</fpage>&#x2013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80903-4</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talley</surname> <given-names>E. M.</given-names></name> <name><surname>Solorzano</surname> <given-names>G.</given-names></name> <name><surname>Lei</surname> <given-names>Q.</given-names></name> <name><surname>Kim</surname> <given-names>D.</given-names></name> <name><surname>Bayliss</surname> <given-names>D. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Cns distribution of members of the two-pore-domain (KCNK) potassium channel family.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>21</volume> <fpage>7491</fpage>&#x2013;<lpage>7505</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-19-07491.2001</pub-id> <pub-id pub-id-type="pmid">11567039</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatsushima</surname> <given-names>Y.</given-names></name> <name><surname>Egashira</surname> <given-names>N.</given-names></name> <name><surname>Matsushita</surname> <given-names>N.</given-names></name> <name><surname>Kurobe</surname> <given-names>K.</given-names></name> <name><surname>Kawashiri</surname> <given-names>T.</given-names></name> <name><surname>Yano</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Pemirolast reduces cisplatin-induced kaolin intake in rats.</article-title> <source><italic>Eur. J. Pharmacol.</italic></source> <volume>661</volume> <fpage>57</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2011.04.026</pub-id> <pub-id pub-id-type="pmid">21539837</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Travagli</surname> <given-names>R. A.</given-names></name> <name><surname>Hermann</surname> <given-names>G. E.</given-names></name> <name><surname>Browning</surname> <given-names>K. N.</given-names></name> <name><surname>Rogers</surname> <given-names>R. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Brainstem circuits regulating gastric function.</article-title> <source><italic>Annu. Rev. Physiol.</italic></source> <volume>68</volume> <fpage>279</fpage>&#x2013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.68.040504.094635</pub-id> <pub-id pub-id-type="pmid">16460274</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>K.</given-names></name> <name><surname>Asano</surname> <given-names>K.</given-names></name> <name><surname>Tasaka</surname> <given-names>A.</given-names></name> <name><surname>Ogura</surname> <given-names>Y.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Ito</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.</article-title> <source><italic>Br. J. Pharmacol.</italic></source> <volume>171</volume> <fpage>2888</fpage>&#x2013;<lpage>2899</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12629</pub-id> <pub-id pub-id-type="pmid">24641692</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Shu</surname> <given-names>S.</given-names></name> <name><surname>Yao</surname> <given-names>S.</given-names></name> <name><surname>Lynch</surname> <given-names>C.</given-names></name> <name><surname>Bayliss</surname> <given-names>D. A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>TASK channels contribute to neuroprotective action of inhalational anesthetics.</article-title> <source><italic>Sc. Rep.</italic></source> <volume>7</volume>:<issue>44203</issue>. <pub-id pub-id-type="doi">10.1038/srep44203</pub-id> <pub-id pub-id-type="pmid">28276488</pub-id></citation></ref>
</ref-list>
</back>
</article>